Perceptive Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-83,386
| Closed | -$388K | – | 162 |
|
|
2017
Q4 | $388K | Hold |
83,386
| – | – | 0.01% | 123 |
|
|
2017
Q3 | $592K | Buy |
+83,386
| New | +$592K | 0.02% | 113 |
|
|
2015
Q3 | – | Sell |
-34,380
| Closed | -$343K | – | 190 |
|
|
2015
Q2 | $343K | Sell |
34,380
-50,000
| -59% | -$499K | 0.02% | 126 |
|
|
2015
Q1 | $1.07M | Buy |
+84,380
| New | +$1.07M | 0.08% | 94 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 164 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 141 |
|
|
2014
Q2 | – | Sell |
-275,000
| Closed | -$4.69M | – | 153 |
|
|
2014
Q1 | $4.69M | Buy |
+275,000
| New | +$4.69M | 0.49% | 43 |
|
|
2013
Q4 | – | Sell |
-200,000
| Closed | -$2.02M | – | 132 |
|
|
2013
Q3 | $2.02M | Buy |
200,000
+150,000
| +300% | +$1.51M | 0.16% | 51 |
|
|
2013
Q2 | $374K | Buy |
+50,000
| New | +$374K | 0.04% | 59 |
|